• LAST PRICE
    2.3000
  • TODAY'S CHANGE (%)
    Trending Up0.0200 (0.8772%)
  • Bid / Lots
    2.0500/ 2
  • Ask / Lots
    2.4000/ 3
  • Open / Previous Close
    2.2103 / 2.2800
  • Day Range
    Low 2.2000
    High 2.3500
  • 52 Week Range
    Low 1.8500
    High 9.6100
  • Volume
    163,000
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.28
TimeVolumeSTTK
09:51 ET1002.2103
09:55 ET8752.2
10:11 ET254002.205
10:13 ET24102.245
10:20 ET9002.25
10:29 ET6002.25
10:31 ET3002.25
10:33 ET5002.24
10:36 ET1002.24
10:38 ET11002.2317
10:40 ET1002.24
10:42 ET8022.23
10:44 ET6002.24
10:45 ET2002.23
10:47 ET3002.23
10:51 ET19192.26
10:56 ET1002.255
11:02 ET1002.255
11:05 ET5002.25
11:07 ET5002.255
11:18 ET1002.23
11:23 ET2542.25
11:25 ET2002.23
11:27 ET193992.25
11:30 ET14292.245
11:38 ET33992.25
11:39 ET1002.23
11:41 ET148002.24
11:43 ET13202.24
11:45 ET2002.24
11:50 ET3002.25
11:57 ET1002.235
11:59 ET12832.25
12:01 ET1002.24
12:03 ET57002.255
12:06 ET10582.25
12:12 ET15892.25
12:15 ET2002.235
12:26 ET3002.24
12:30 ET7002.24
12:32 ET2002.24
12:35 ET2002.2275
12:44 ET1002.24
12:46 ET1002.24
01:06 ET1002.24
01:31 ET1002.235
01:33 ET2002.24
01:36 ET1002.24
01:38 ET177082.25
01:40 ET3002.27
01:51 ET1002.25
02:02 ET1002.25
02:12 ET2142.255
02:25 ET23782.26
02:27 ET7002.27
02:32 ET3002.29
02:34 ET21932.28
02:36 ET1072.31
02:43 ET1342.2994
02:50 ET7002.3
02:52 ET1002.3
03:10 ET7202.3
03:21 ET2002.3
03:39 ET99262.3
03:42 ET1412.285
03:44 ET1002.3
03:46 ET1452.3
03:53 ET20002.29
03:55 ET38002.29
03:57 ET93932.315
04:00 ET42982.3
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSTTK
Shattuck Labs Inc
96.7M
-1.4x
---
United StatesSLGL
Sol Gel Technologies Ltd
108.2M
28.6x
---
United StatesIKNA
Ikena Oncology Inc
80.9M
-1.5x
---
United StatesSESN
Sesen Bio Inc
109.5M
-32.1x
---
United StatesFIXX
Homology Medicines Inc
84.5M
-15.7x
---
United StatesPIRS
Pieris Pharmaceuticals Inc
73.6M
-2.1x
---
As of 2022-12-06

Company Information

Shattuck Labs, Inc. is a clinical-stage biotechnology company, which is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. SL-172154 is in an ongoing Phase I clinical trial for the treatment of patients with ovarian cancer. It is also evaluating SL-172154 in an ongoing Phase I clinical trial for the treatment of patients with certain hematologic malignancies, including acute myeloid leukemia and higher-risk myelodysplastic syndromes. Its second product candidate, SL-279252, is designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 costimulatory receptor and is in an ongoing Phase I clinical trial in patients with advanced solid tumors.

Contact Information

Headquarters
500 W. 5Th Street, Suite 100AUSTIN, TX, United States 78701
Phone
512-900-4690
Fax
---

Executives

Independent Chairman of the Board
George Golumbeski
Chief Executive Officer, Co-Founder, Director
Taylor Schreiber
Chief Financial Officer
Andrew Neill
General Counsel
Erin Thomson
Chief Business Officer
Casi Deyoung

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$96.7M
Revenue (TTM)
$30.3M
Shares Outstanding
42.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.62
Book Value
$6.42
P/E Ratio
-1.4x
Price/Sales (TTM)
3.2
Price/Cash Flow (TTM)
---
Operating Margin
-223.49%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.